Hematology (157052) 1994 / Chronic / Medical Oncology (157052) Active License / Internal Medicine (157052) 1997 / ACS / Onyx Pharmaceuticals / /
Currency
USD / pence / SLL / / /
Event
FDA Phase / /
Facility
College of Veterinary Medicine / Howard Hughes Medical Institute / College of Pharmacy / Ohio State University / B305 Starling Loving Hall / Walter Reed Army Medical Center / CCC Wiseman Hall / M.D. Hendrix College / University of Health Sciences / University of Arkansas / College of Medicine / Johns Hopkins University / /
IndustryTerm
Cancer Therapy / therapeutics of leukemia / culture services / tissue bank / treatment for hematological cancers / /
MedicalCondition
lymphocytic leukemia / acute lymphoblastic leukemia PI / leukemia / tumor / cancer / Chronic / CLL tumor / gastro-intestinal and hematopoietic cancers / hematological cancers PI / cytokine release syndrome / acute leukemias / hematologic malignancy / lymphoma / B cell Lymphoma / relapsed chronic lymphocytic leukemia / Chronic Lymphocytic Leukemia / Chronic Lymphocytic Leukemia PI / Relapsed Chronic Lymphocytic Leukemia PI / experimental design Chronic / lymphocytic leukemia research consortium / Scientific Collaborator Chronic / Minimal Residual Disease / disease / chronic lymphocytic leukemia/small lymphocytic lymphoma / Hematologic Malignancies / primary malignant hematopoietic tumor / lung cancer / subsequent cancer / CRC tissue bank Chronic / refractory chronic lymphocytic leukemia PI / small lymphocytic lymphoma / /
Univ of CA / American Board of Medical Oncology / College of Pharmacy / American Board of Internal Medicine / Department of Internal Medicine / Leukemia Research Foundation / Clinical Trials Unit / University of Health Sciences / Christoph Plass PhD Agency / Walter Reed Army Medical Center Comprehensive Cancer Center / The Ohio State University School of Medicine and Public Health / Department of Medicine / John C. Byrd MD/Tridandapani Agency / American Society of Clinical Oncology Goal / OSU Comprehensive Cancer Center / American Board of Hematology / The Ohio State University / College of Veterinary Medicine / National Institute of Health / Lymphoma Research Foundation / Muthusamy Agency / Walter Reed Army Medical Center / Executive Committee / Johns Hopkins University / University of Arkansas / Michael Freitas PhD Agency / American Society of Clinical Oncology/Fellowship Goal / Univ of California / Hendrix College / Amy Johnson PhD Agency / Woyach Agency / School of Medicine and Public Health / John C. Byrd MD/Johnson Agency / Department of Oncology / John C. Byrd MD/ Muthusamy Agency / Ohio State University Comprehensive Cancer Center / College of Medicine / LLS / Howard Hughes Medical Institute / Clinical Trials Office / /
Person
Jennifer A. Woyach / Jennifer A Woyach / Walter Reed / Tyrosine Kinase / Aparna Raval / Sherif S. Farag / Michael Grever / Erin Hertlein / Thomas Lin / Sam Jacob / Jeffrey Jones / Michael Freitas / Rebekah Browning Mentor / Mayo Fdn / JOHN C. BYRD / Jennifer Woyach / Neil Kay / Vivek Abyhanker / Amy Johnson / Samantha M. Jaglowski / Kristie Blum / Guido Marcucci / Christoph Plass / Kami J. Maddocks-Christianson / Leslie Andritsos / Carlo Croce / Miguel Villalona / Michael Caligiuri / Albert de la Chapelle / William Blum / D. Warren Brown / / /
Position
Innate Immune Therapy Program Co-Leader / Director / Division / Medical Co-Director / Assistant Chief / Division / Professor / Professor of Medicinal Chemistry / Associate Professor / Professor of Oncology / Associate Director for Translational Research / Professor of Medicine / Director for this project and serves / Principal Investigator / Medical Director / Director / Clinical Research / Division / Co-Investigator / Professor of Veterinary Bioscience / Director / Section / Director / Inpatient Leukemia Service / Division / ASCO/Young Investigator / independent clinical investigator / Interim Co-Director / Division / Diplomat / Interim Director / Division / Co-Leader / Chair / Director for this project / Visiting Assistant / /